Aurore Morello

Company: OSE Immunotherapeutics

Job title: Research

Seminars:

Revealing Cytomask®: Cis-Demasking Cytokine Technology for Targeted Delivery 1:40 pm

Outlining masking cytokine technology, allowing activity on-demand at the Right Site but suffers from enzyme selectivity Cis-delivery cytokine technology allows redirection of activity on the right cells but requires potent cytokine attenuation and non-optimal cell selectivity Cytomask® is a novel Cis-Demasking cytokine technology avoiding cytokine attenuation and lack of selectivity of cleavable linkers to unmask…Read more

day: Conference Day One